Califano R - Search Results

1

Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer.

Qiu B, Cai K, Chen C, Chen J, Chen KN, Chen QX, Cheng C, Dai TY, Fan J, Fan Z, Hu J, Hu WD, Huang YC, Jiang GN, Jiang J, Jiang T, Jiao WJ, Li HC, Li Q, Liao YD, Liu HX, Liu JF, Liu L, Liu Y, Long H, Luo QQ, Ma HT, Mao NQ, Pan XJ, Tan F, Tan LJ, Tian H, Wang D, Wang WX, Wei L, Wu N, Wu QC, Xiang J, Xu SD, Yang L, Zhang H, Zhang L, Zhang P, Zhang Y, Zhang Z, Zhu K, Zhu Y, Um SW, Oh IJ, Tomita Y, Watanabe S, Nakada T, Seki N, Hida T, Sasada S, Uchino J, Sugimura H, Dermime S, Cappuzzo F, Rizzo S, Cho WC, Crucitti P, Longo F, Lee KY, De Ruysscher D, Vanneste BGL, Furqan M, Sieren JC, Yendamuri S, Merrell KW, Molina JR, Metro G, Califano R, Bongiolatti S, Provencio M, Hofman P, Gao S, He J. Qiu B, et al. Among authors: califano r. Transl Lung Cancer Res. 2021 Sep;10(9):3713-3736. doi: 10.21037/tlcr-21-634. Transl Lung Cancer Res. 2021. PMID: 34733623 Free PMC article. Review. No abstract available.

2

Prognostic and predictive value of K-RAS mutations in non-small cell lung cancer.

Califano R, Landi L, Cappuzzo F. Califano R, et al. Drugs. 2012 Jun 19;72 Suppl 1:28-36. doi: 10.2165/1163012-S0-000000000-00000. Drugs. 2012. PMID: 22712795 Review.

3

Beyond EGFR and ALK inhibition: unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer.

Califano R, Abidin A, Tariq NU, Economopoulou P, Metro G, Mountzios G. Califano R, et al. Cancer Treat Rev. 2015 May;41(5):401-11. doi: 10.1016/j.ctrv.2015.03.009. Epub 2015 Mar 28. Cancer Treat Rev. 2015. PMID: 25842168 Review.

4

Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis.

Genestreti G, Tiseo M, Kenmotsu H, Kazushige W, Di Battista M, Cavallo G, Carloni F, Bongiovanni A, Burgio MA, Casanova C, Metro G, Scarpi E, Korkmaz T, Selcuk S, Roopa K, Califano R. Genestreti G, et al. Among authors: califano r. Clin Lung Cancer. 2015 Nov;16(6):e223-8. doi: 10.1016/j.cllc.2015.04.006. Epub 2015 Apr 24. Clin Lung Cancer. 2015. PMID: 25983005

5

Outcomes of octogenarian (≥ 80 yo) patients with advanced non-small cell lung cancer (NSCLC): A single institution experience at the Christie Hospital.

Howell M, Chiramel J, Flaum N, Lewis A, Summers Y, Taylor PD, Chittalia A, Sheikh H, Blackhall F, Califano R. Howell M, et al. Among authors: califano r. Lung Cancer. 2016 Jan;91:75-6. doi: 10.1016/j.lungcan.2015.10.024. Epub 2015 Oct 28. Lung Cancer. 2016. PMID: 26621386 No abstract available.

6

Management of NSCLC Disease Progression After First-Line EGFR Tyrosine Kinase Inhibitors: What Are the Issues and Potential Therapies?

Califano R, Romanidou O, Mountzios G, Landi L, Cappuzzo F, Blackhall F. Califano R, et al. Drugs. 2016 May;76(8):831-40. doi: 10.1007/s40265-016-0578-z. Drugs. 2016. PMID: 27129321 Review.

7

Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancer.

Romanidou O, Landi L, Cappuzzo F, Califano R. Romanidou O, et al. Among authors: califano r. Ther Adv Med Oncol. 2016 May;8(3):176-87. doi: 10.1177/1758834016631531. Epub 2016 Feb 16. Ther Adv Med Oncol. 2016. PMID: 27239236 Free PMC article. Review.

8

Immunotherapy in tyrosine kinase inhibitor-naïve advanced epidermal growth factor receptor-mutant non-small cell lung cancer-driving down a precarious road in driver-mutated lung cancer.

Tay RY, Ackermann CJ, Califano R. Tay RY, et al. Among authors: califano r. Transl Lung Cancer Res. 2018 Dec;7(Suppl 4):S377-S380. doi: 10.21037/tlcr.2018.09.16. Transl Lung Cancer Res. 2018. PMID: 30705861 Free PMC article. No abstract available.

9

Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts.

Früh M, Panje CM, Reck M, Blackhall F, Califano R, Cappuzzo F, Besse B, Novello S, Garrido P, Felip E, O'Brien M, Paz Ares L, de Marinis F, Westeel V, De Ruysscher D, Putora PM. Früh M, et al. Among authors: califano r. Lung Cancer. 2020 Aug;146:6-11. doi: 10.1016/j.lungcan.2020.03.024. Epub 2020 Mar 30. Lung Cancer. 2020. PMID: 32485661

10

Integrating immune checkpoint inhibitors and targeted therapies in the treatment of early stage non-small cell lung cancer: a narrative review.

Ortega-Franco A, Calvo V, Franco F, Provencio M, Califano R. Ortega-Franco A, et al. Among authors: califano r. Transl Lung Cancer Res. 2020 Dec;9(6):2656-2673. doi: 10.21037/tlcr-20-546. Transl Lung Cancer Res. 2020. PMID: 33489825 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page